Jean-Pierre Després Selected Research

HDL Cholesterol

1/2019	The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
10/2018	Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.
1/2018	Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy.
1/2016	Computed tomography-measured adipose tissue attenuation and area both predict adipocyte size and cardiometabolic risk in women.
7/2014	Waist circumference as a vital sign in cardiology 20 years after its initial publication in the American Journal of Cardiology.
10/2013	Improved plasma FFA/insulin homeostasis is independently associated with improved glucose tolerance after a 1-year lifestyle intervention in viscerally obese men.
2/2013	HDL cholesterol studies--more of the same?
1/2013	Pathophysiology of human visceral obesity: an update.
10/2012	Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity.
8/2012	Angiographically-assessed coronary artery disease associates with HDL particle size in women.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Pierre Després Research Topics

Disease

38	Insulin Resistance 01/2021 - 03/2004
37	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014 - 04/2003
36	Abdominal Obesity 01/2020 - 07/2002
34	Obesity 01/2021 - 05/2002
28	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2004
21	Coronary Disease (Coronary Heart Disease) 12/2016 - 11/2002
20	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 07/2002
18	Inflammation (Inflammations) 01/2019 - 01/2004
18	Body Weight (Weight, Body) 06/2018 - 11/2002
17	Dyslipidemias (Dyslipidemia) 01/2021 - 01/2003
17	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 11/2002
16	Overweight 01/2020 - 05/2003
15	Atherosclerosis 01/2019 - 11/2002
15	Weight Loss (Weight Reduction) 02/2015 - 07/2003
14	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 01/2008
12	Hypertriglyceridemic Waist 01/2018 - 07/2002
10	Hypertriglyceridemia 01/2021 - 07/2002
10	Hypertension (High Blood Pressure) 12/2016 - 12/2004
7	Weight Gain 01/2021 - 01/2002
7	Pathologic Constriction (Stenosis) 01/2017 - 01/2008
7	Glucose Intolerance 07/2014 - 05/2002
5	Hyperinsulinism (Hyperinsulinemia) 07/2014 - 02/2007
5	Myocardial Ischemia (Ischemic Heart Diseases) 10/2007 - 08/2002
4	Aortic Valve Disease 01/2015 - 10/2012
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2017
3	Diabetes Mellitus 01/2018 - 02/2005
3	Neoplasms (Cancer) 11/2016 - 05/2010
3	Hyperlipidemias (Hyperlipidemia) 01/2016 - 11/2003
3	Disease Progression 01/2014 - 04/2008
3	Hypercholesterolemia 08/2012 - 09/2008
3	Atrial Fibrillation 01/2012 - 09/2007
3	Nausea 02/2008 - 11/2005
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2008 - 06/2004
2	Morbid Obesity 01/2020 - 12/2012
2	Vitamin D Deficiency 01/2020 - 11/2016
2	Death (Near-Death Experience) 01/2020 - 09/2015
2	Carotid Artery Diseases 01/2018 - 07/2011
2	Hypertrophy 01/2016 - 04/2010
2	Hypotension (Low Blood Pressure) 06/2012 - 02/2011

Drug/Important Bio-Agent (IBA)

47	LipidsIBA 01/2020 - 01/2003
43	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2002
38	HDL CholesterolIBA 01/2019 - 07/2002
36	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2002
36	oxidized low density lipoproteinIBA 01/2019 - 01/2003
28	Insulin (Novolin)FDA Link 01/2020 - 07/2002
24	CholesterolIBA 10/2018 - 07/2002
22	Lipoproteins (Lipoprotein)IBA 10/2018 - 01/2003
19	ApolipoproteinsIBA 01/2017 - 07/2002
16	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017 - 07/2002
13	Apolipoproteins B (ApoB)IBA 01/2020 - 01/2003
12	AdiponectinIBA 11/2018 - 02/2005
12	LDL CholesterolIBA 02/2013 - 05/2003
11	C-Reactive ProteinIBA 01/2013 - 03/2003
10	HDL LipoproteinsIBA 10/2018 - 10/2003
10	RimonabantIBA 07/2011 - 11/2005
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2005
8	Interleukin-6 (Interleukin 6)IBA 01/2014 - 01/2003
6	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2018 - 02/2007
5	LeptinIBA 01/2020 - 01/2002
5	Rosiglitazone (Avandia)FDA Link 01/2019 - 09/2009
5	Rosuvastatin Calcium (Crestor)FDA Link 01/2017 - 04/2010
5	Adenosine Triphosphate (ATP)IBA 12/2014 - 06/2008
5	CannabinoidsIBA 03/2009 - 06/2007
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 03/2009 - 11/2005
4	Lipoprotein(a)IBA 01/2020 - 08/2002
4	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 02/2011
4	CalciumIBA 01/2014 - 06/2003
3	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021 - 12/2014
3	1-penicillamyl-Leu(2)- oxytocinIBA 01/2020 - 09/2015
3	Blood Glucose (Blood Sugar)IBA 01/2018 - 07/2002
3	EndocannabinoidsIBA 01/2013 - 01/2009
3	CytokinesIBA 01/2013 - 01/2006
3	Fibrinogen (Factor I)FDA Link 02/2011 - 10/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 10/2006
3	Pharmaceutical PreparationsIBA 06/2007 - 07/2003
2	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021 - 04/2004
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 04/2004
2	Olanzapine (Zyprexa)FDA Link 01/2021 - 04/2004
2	Vitamin D FDA LinkGeneric 01/2020 - 11/2016
2	hydroxide ionIBA 01/2020 - 11/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2018
2	C-PeptideIBA 06/2018 - 10/2004
2	AdipokinesIBA 01/2018 - 01/2006
2	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 02/2008
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 09/2014 - 06/2010
2	N 30IBA 01/2014 - 11/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 11/2009
2	Nonesterified Fatty Acids (NEFA)IBA 10/2013 - 01/2013
2	lipoprotein cholesterolIBA 04/2013 - 06/2012
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2013 - 10/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012 - 01/2012

Therapy/Procedure

9	Therapeutics 01/2018 - 11/2002
8	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2013 - 08/2007
4	Bariatric Surgery 01/2021 - 12/2012
3	Glycemic Control 12/2012 - 01/2009
3	Drug Therapy (Chemotherapy) 11/2012 - 11/2009
2	Biliopancreatic Diversion 01/2016 - 12/2012
2	Obesity Management 01/2015 - 04/2008
2	Stents 01/2014 - 11/2009